Schizophrenia is a mental disorder affecting an estimated one half to one percent of the global population. Contradictory to popular belief, schizophrenia does not deal with multiple personalities. Rather, the disorder can cause hallucinations, paranoia or bizarre delusions and disorganized thought or speech pattern. People with schizophrenia often have other mental disorders (Sim et al. 2006). Thus schizophrenia can result in socially paralysing an individual. Treatment and prevention of the disorder are important steps in helping millions of people. One vital point in the process of developing a treatment and prevention strategy for schizophrenia is identifying the cause or causes of the disorder.
Throughout the years, as examination into schizophrenia has advanced, the comprehension of schizophrenia has made strides. Researchers have possessed the capacity to pinpoint conceivable causes in the earth and the hereditary qualities of people that have schizophrenia, for instance. These headways thus have took into account the making of clearer models of how schizophrenia creates in people. The point of this article is to clear up the present perspective on what causes schizophrenia. The improvement of causation models will be talked about notwithstanding expounding on conceivable ecological and organic causal elements of schizophrenia.
Amid the numerous years of exploration on the reasons for schizophrenia, a few diverse models have been proposed. The scope of models has been proposed to be because of the tending to various parts of the sickness, or perhaps ailments, we call schizophrenia (Keshavan et al. 2008). Another component in the scope of models is assortment of courses in which schizophrenia shows (Peralta and Cuesta 2000). A few etiological models have possessed the capacity to represent numerous components of schizophrenia. For instance, in 1995, Olney and Faber recommended that NDMA receptor hypofunction might have the capacity to clarify numerous manifestations of schizophrenia, both mental and organic (refered to in Keshavan et al. 2008). In spite of the fact that the hypothesis appears to have a few textures with the hereditary causalities thought to be identified with schizophrenia, for example, no authoritative proof has been found to demonstrate the model right . Another model set forth by Crow in 1995 proposes that a "desynchrony of hemispheric advancement because of gene(s) required in development of dialect" would clarify a few parts of schizophrenia (Keshavan et al. 2008, p.101). however another proposed model recommends that stretch might be the causal trigger in people (Corcoran et al. 2003). Be that as it may, this model would not completely clarify why a few people are inclined to schizophrenia while others are definitely not. Moreover, it has been recommended that a reasonable model for the reasons for schizophrenia be wrong (Keshavan et al. 2008). This proposition could unquestionably hold some legitimacy and record for the expansive scope of appearances in patients determined to have schizophrenia.
Hereditary Causes Research demonstrates that a mix of hereditary weakness and natural elements can prompt schizophrenia (Harrison and Owen 2003), and that the hereditary issues prompting this ailment are brought about by various elements and diverse qualities (Owen et al. 2005). Be that as it may, the heritability of schizophrenia has been difficult to gauge as a result of the trouble of isolating hereditary and natural causes (O'Donovan et al. 2003). Research made on twins has found an abnormal state of heritability, and proposed that quality elements are the fundamental driver of the illness . The hypothesis of hereditary causation additionally contends that schizophrenia is a sickness of complex legacy; in this manner, research has concentrated on finding the gathering of qualities that may precipitate this mental issue (Owen et al. 2005). It was evaluated that a gathering of fourteen qualities might be causal, yet late research demonstrates that the proposed gathering of qualities is not connected with schizophrenia (Sanders et al. 2008). In a few patients, schizophrenia might be brought about by cancellations or duplications of DNA arrangements in qualities that are in charge of neuronal signalization or mental health (Walsh et al. 2008). This prompts neural procedures that may bring about maniacal issue, for example, schizophrenia. For instance, a basic anomaly of the mind, for example, contrasts of the volume of dim matter in a few ranges of the cerebrum, prompts lessening in the measure of neurons, which can bring about crazy disorders (Hoffman and McGlashan 2001). Research demonstrates that such irregularity can be available from the introduction of the subject, or it might grow later due to causes other than quality powerlessness. Other exploration demonstrates that the issue might be in the neural system and will influence the working of the brainSuch perceptions demonstrate that there is a competition between various neural systems that may prompt the deactivation of one of them and accordingly upset the capacity of some zone of the cerebrum.
This clarifies the vast majority of the indications identified with schizophrenia, for example, memory misfortune, consideration issue, social discernment and issues with official capacities. The capacity of dopamine in the mesolimbic and mesocortial pathways of the mind has been given specific consideration in exploration on the reasons for schizophrenia. Taking into account drug analyzes, the "dopamine theory of schizophrenia" recommends that a glitch around there causes the confusion's manifestations (Seeman et al. 2005). Proof incorporates discoveries that qualities coding for systems required in dopamine capacity might be more predominant in schizophrenics (Arguello and Gogos 2008). In any case, later research recommends that over the top dopamine capacity not be the sole reason for schizophrenia side effects. Specifically, low levels of glutamate, another neurotransmitter, have been found to deliver comparable impacts (Lahti et al. 2001).
Drug Use Strong confirmation demonstrates that utilization of certain medications can go about as a trigger for either the onset or backslide of schizophrenia in some individuals. Cannabis has been connected to schizophrenia most as often as possible; other suspected triggers incorporate amphetamines and drugs. The relationship amongst schizophrenia and medication use, in any case, has been observed to be perplexing. A reasonable causal association between substance utilize and clutter has therefore not been set up yet. Schizophrenia 8 Most proof for a connection between medication use and schizophrenia has been found in examination on the impacts of cannabis. Thinks about propose that the medication altogether expands the danger of creating schizophrenia, however found that it is neither an adequate nor a vital element in building up the confusion (Arsenault, Cannon, Witton, and Murray, 2004). Or maybe, it is expected that it is one and only of a mind boggling blend of components bringing on the turmoil (on the same page.). As per a survey of studies led by Arsenault et al (in the same place.), cannabis pairs the danger of creating schizophrenia on the individual level, and could, a causal relationship expected, represent 8% percent of cases in the general populace. Other than cannabis, psychedelic drugs and stimulant medications, for example, amphetamines have been connected to bringing about schizophrenia. Amphetamines may intensify schizophrenia manifestations, since the medication triggers the arrival of dopamine (Laruelle et al. 1996). Overwhelming utilization of psychedelic drugs as additionally been found to now and then trigger schizophrenia (Mueser at al. 1990). Be that as it may, both amphetamines and stimulating medications, similar to cannabis, have been observed to be neither adequate nor fundamental variables in clarifying the turmoil's improvement. By and by, when an inclination exists, these medications may trigger the onset or backslide of schizophrenia.
Flow research proposes that schizophrenia is a confusion brought on by a mind boggling set of interrelated elements. Hereditary inclinations, ecological impacts, and medications, for example, cannabis have been analyzed in quest for what causes schizophrenia. In any case, unification of individual discoveries stays troublesome, likewise in light of the fact that the finding depends on side effect profiles, compose Marcotte et al. (2001): "Ebb and flow research into schizophrenia has remained profoundly divided, much like the clinical presentation of the malady itself." Further research appears to be vital keeping in mind the end goal to comprehend the neural procedures identified with schizophrenia. Seeman (2010) recommends that "all streets to schizophrenia lead to dopamine supersensitivity"; in any case, there are sensible questions about the omnibus case of the dopamine hypothesis of schizophrenia (Lahti et al. 2001). Actually, neural relates don't give adequate criteria to analyze schizophrenia (Manji et al. 2003). For the occasion, what precisely causes schizophrenia remains an inquiry that can't yet be replied.
Ebb and flow research recommends that schizophrenia is a turmoil brought about by a mind boggling set of interrelated components. Hereditary inclinations, ecological impacts, and medications, for example, cannabis have been analyzed in quest for what causes schizophrenia. Notwithstanding, unification of individual discoveries stays troublesome, additionally on the grounds that the finding depends on manifestation profiles, compose Marcotte et al. (2001): "Flow research into schizophrenia has remained exceptionally divided, much like the clinical presentation of the infection itself." Further research appears to be fundamental with a specific end goal to comprehend the neural procedures identified with schizophrenia. Seeman (2010) recommends that "all streets to schizophrenia lead to dopamine supersensitivity"; in any case, there are sensible questions about the omnibus case of the dopamine hypothesis of schizophrenia (Lahti et al. 2001). Truth be told, neural relates don't give adequate criteria to analyze schizophrenia (Manji et al. 2003). For the occasion, what precisely causes schizophrenia remains an inquiry that can't yet be replied.

Work Cited
Arguello PA, Gogos JA. 2008. A signaling pathway AKTing up in schizophrenia. J Clin Invest 118(6): 2018–2021. Arsenault L, Cannon M, Witton J, Murray, RM. 2004. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-7.
Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, Sonuga-
Barke EJS. 2009. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 33(3):
279-96.
Cantor-Graae E, Selten JP. 2005. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162(1): 12-24. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina
D. 2003. The Stress Cascade and Schizophrenia: Etiology and
Onset. Schizophrenia Bull 29(4): 671-92.
Harris A. 2010. Pharmacological Treatment of Schizophrenia [Lecture on the Internet]. 2010. Sydney: University of Sydney [cited 2010 Nov 8]. Available from: http://sydney.edu.au/medicine/psychiatry/workshops/ presentations/pharmacological_treatment_schiz.pdf
Harrison PJ, Owen MJ. 2003. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361(9355): 417-9.
Hoffman RE, McGlashan TH. 2001. Neural network models of schizophrenia. Neuroscientist 7: 441-54.
Janssen I, Krabbendam L, Bak M, et al. 2004. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 109 (1): 38-45.
Jones SR, Fernyhough C. 2007. A New Look at the Neural Diathesis Stress Model of Schizophrenia: The Primacy of Social-Evaluative and Uncontrollable Situations. Schizophrenia Bull 33(5): 1171-
177.
Keshavan MS, Tandon R, Boutros NN, Nasrallah HH. 2008.
Schizophrenia, “just the Facts”: What We Know in 2008 Part 3:
Neurobiology. Schizophrenia Res 106(2-3): 89-107. Krabbendam L, van Os J. 2005. Schizophrenia and urbanicity: a major environmental influence conditional on genetic risk. Schizophr
Bull 31(4): 795-9.
Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA.
2001. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25(4): 455–67.
Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J,
McCance E, Rosenblatt W, Fingado C, Zoghbi SS, et al. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Nat Acad Sci USA 93(17): 9235-40.
MacMillan HL, Fleming JE, Streiner DL, et al. 2001. Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry 158 (11): 1878-83.
Manji HK, Gottesman II, Gould TD. 2003. Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE 2003(207): pe49.
Marcotte ER, Pearson DM, Srivastava LK. 2001. Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 26(5): 395–410.
Mueser KT, Yarnold PR, Levinson DF, et al. 1990. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16 (1): 31-56.
Mueser KT, McGurk SR. 2004. Schizophrenia. The Lancet 363 (9426): 2063-72.
O'Donovan MC, Williams NM, Owen MJ. 2003. Recent advances in the genetics of schizophrenia. Hum Mol Genet 12(2): 125-33. Owen MJ, Craddock N, O'Donovan MC. 2005. Schizophrenia: genes at last?. Trends Genet 21(9): 518-25.
Pedersen CB, Mortensen PB. 2001. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58(11): 1039-46. Peralta V, Cuesta MJ. 2000. Clinical Models of Schizophrenia: A Critical
Approach to Competing Conceptions. Psychopathology 33(5):
252-58.
Read J, Perry BD, Moskowitz A, Connolly J. 2001. The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry 64(4): 319- 45.
Schizophrenia 14
Read J, van Os J, Morrison AP, Ross CA. 2005. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 112(5): 330-50.
Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, et al. 2008. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165(4): 497-506.
Schenkel LS, Spaulding WD, DiLillo D, Silverstein SM. 2005. Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits. Schizophr Res 76 (2-3): 273-86.
Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, et al. 2005. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Nat Acad Sci USA 102(9): 3513–18.
Seeman P. 2010. All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2 Receptors [Internet]. CNS Neurosci Ther [cited 2010 Nov 14]. DOI: 10.1111/j.1755-5949.2010.00162.x
Selten JP, Cantor-Graae E, Kahn RS. 2007. Migration and
Schizophrenia 15 schizophrenia. Curr Opin Psychiatry 20(2): 111-115. Sim K, Chua TH, Chan YH, Mahendran R, Chong SA. (2006).
Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study. J Psychiatric Res 40(7):656–63. Sundquist K, Frank G, Sundquist J. 2004. Urbanisation and incidence of psychosis and depression: follow-up study of 4.4 million women and men in Sweden. Br J Psychiatry 184: 293-8. van Os J. 2004. Does the urban environment cause psychosis?. Br J
Psychiatry 184: 287-8.
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper
GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875): 539-43.
Wicks S, Hjern A, Gunnell D, Lewis G, Dalman C. 2005. Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am J Psychiatry 162 (9): 1652-7.